Mr. Hodges has been involved in the pharmaceutical industry for over 30 years and founded the Metrics business in 1994. Since 1994, Mr. Hodges oversaw the transition of Metrics from a start-up analytical laboratory with four employees to a specialty pharmaceutical company with a portfolio of niche generic products. Prior to starting Metrics, Mr. Hodges spent 11 years at Burroughs Wellcome Co. (which became part of GSK) in the development and validation of analytical methods. Mr. Hodges ceased his executive role as President of Metrics on 31 December 2013 but continues as a Non-Executive Director of Mayne Pharma Group Limited. He is Chair of Chesson Laboratories, Associates, Inc.